Daniel G. Welch - Feb 7, 2023 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)

Role
Director
Signature
/s/ Jun Yoon, Attorney-in-Fact
Stock symbol
GPCR
Transactions as of
Feb 7, 2023
Transactions value $
$0
Form type
4
Date filed
2/9/2023, 06:12 PM
Previous filing
Feb 2, 2023
Next filing
Mar 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GPCR Ordinary Shares Conversion of derivative security +124K 124K Feb 7, 2023 By spouse F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GPCR Series B Preferred Shares Conversion of derivative security -124K -100% 0 Feb 7, 2023 Ordinary Shares 124K By spouse F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All outstanding Preferred Shares automatically converted into Ordinary Shares immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one Ordinary Share for each one Preferred Share, based on the conversion price currently in effect. The Preferred Shares have no expiration date.